The UroGPO team joined the AUS team in Chicago for its APC Champs 2.0 program. It was impressive how quickly AUS has integrated APC therapies for its patient population of men with prostate cancer.
The passion and excitement of the navigator and administrator staff was palpable as they push their extended urology team to optimize intra-practice patient referrals. Kristyn Minetti (APC nurse navigator), Eliza Roque (manager), Donna Erickson (director of ancillary services) and Linda Mathis have been a driving force in AUS’ APC success. In speaking with Kristyn, she was eager to standardize the APC referral trigger and gain 100% compliance from team members. Additionally, she was excited to begin leveraging data platforms for optimal patient identification and monitoring. From the UroGPO perspective, these components of an APC specialist model have been key to unlocking patient treatment consistency and superior practice economics.
Notable initiatives in the works include APC marketing via patient brochures and web, defined scanning, monitoring and treatment protocols, and established APC success metrics. We look forward to seeing further success from this APC team.
UroGPO’s uTrack portal: Know your widgets
The uTrack portal has a wealth of information to optimize your member contract performance. Take advantage of the UroGPO product widgets so you don’t miss contract thresholds at quarter end.
The uTrack portal is your tool for accessing and assessing your active member contracts. uTrack pulls data for monitoring performance toward volume, tier or market share goals (depending on contract requirements), as well as subsequent rebate performance.
uTrack access can be granted to multiple practice members, and we encourage you to share performance goal information with relevant practice team members. Successful planning will prevent end-of-quarter rushes and allow for more consistent patient scheduling and manageable workloads.
We have activated three new widgets for the Endo portfolio of urology products with quarterly goals, Xiaflex, Aveed and Valstar. Review your data to plan for quarter-end.